EUVIMEDEUVIMED entdecken
Crossref

Polymorphism-Dependent Bioefficacy of the Prodrug Propionylbrassinolide at Ultra-Low Concentrations

Chengli Liu, Chenghao Wang, Zhiwei Miao, Yuteng Han, Xiaofang Niu, Jingxiang Yang

Crystal Growth & Design · 03.11.2026

DOI: 10.1021/acs.cgd.6c00546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Crystal Growth & Design, online erschienen am 03.11.2026. Verfasst von Chengli Liu und 5 weiteren Autor:innen. Die Arbeit nennt 66 Literaturangaben. Gefördert von: Natural Science Foundation of Tianjin Municipality, Nankai University, National Key Research and Development Program of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polymorphism is widely recognized to alter the bioavailability of active ingredients. Nevertheless, polymorphism-dependent biological behavior at ultra-low concentrations (nM level) has seldom been reported, owing to the intuitive assumption that compounds exist solely as dissolved molecules under these conditions. This assumption is particularly widespread for hormones, which exert potent biological effects and mediate biological regulation at nanomolar to micromolar levels. Consequently, the potential role of solid-state chemistry of these compounds has remained largely unexplored. Herein, we demonstrate that the phytohormone propionylbrassinolide (PB) exhibits pronounced polymorphism-dependent bioefficacy even at 8.5 nM, with Form II consistently displaying higher activity than Form I in rice seed germination assays. The aqueous solubility of PB (<0.05 nM) is far below this application concentration, suggesting that a substantial solid-phase fraction can persist even at nanomolar dosing levels. Differences in solid-state hydrolysis kinetics between the two polymorphs may contribute to their distinct bioefficacy, potentially involving hydrolytic activation of the prodrug. These results uncover a previously unrecognized solid-state dimension of bioactive compounds applied at ultra-low concentrations and highlight the importance of considering the solid-state chemistry of phytohormones.

Förderung

  • Natural Science Foundation of Tianjin Municipality
  • Nankai University
  • National Key Research and Development Program of China
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Frontiers Science Center for New Organic Matter, Nankai University

Zitieren

APA

Liu, C., Wang, C., Miao, Z., Han, Y., Niu, X., & Yang, J. (2026). Polymorphism-Dependent Bioefficacy of the Prodrug Propionylbrassinolide at Ultra-Low Concentrations. Crystal Growth & Design. https://doi.org/10.1021/acs.cgd.6c00546

Vancouver

Liu C, Wang C, Miao Z, Han Y, Niu X, Yang J. Polymorphism-Dependent Bioefficacy of the Prodrug Propionylbrassinolide at Ultra-Low Concentrations. Crystal Growth & Design. 2026. doi:10.1021/acs.cgd.6c00546

BibTeX
@article{Liu2026,
  author = {Liu, Chengli and Wang, Chenghao and Miao, Zhiwei and Han, Yuteng and Niu, Xiaofang and Yang, Jingxiang},
  title = {Polymorphism-Dependent Bioefficacy of the Prodrug Propionylbrassinolide at Ultra-Low Concentrations},
  journal = {Crystal Growth & Design},
  year = {2026},
  doi = {10.1021/acs.cgd.6c00546}
}
Kostenlos starten →